-
1
-
-
28944454399
-
Long-term efficacy of levetiracetam for partial seizures
-
Abou-khalil B., and Schaich L. Long-term efficacy of levetiracetam for partial seizures. Seizure 14 (2005) 577-585
-
(2005)
Seizure
, vol.14
, pp. 577-585
-
-
Abou-khalil, B.1
Schaich, L.2
-
2
-
-
0028937118
-
Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial seizures
-
The International Gabapentin Study Group
-
Anhut H., Ashman P.J., Feuerstein T.J., Quebe-Fehling E., Saunders M., Baron B.A., and The International Gabapentin Study Group. Long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in patients with refractory partial seizures. J. Epilepsy 8 1 (1995) 44-50
-
(1995)
J. Epilepsy
, vol.8
, Issue.1
, pp. 44-50
-
-
Anhut, H.1
Ashman, P.J.2
Feuerstein, T.J.3
Quebe-Fehling, E.4
Saunders, M.5
Baron, B.A.6
-
3
-
-
0001196981
-
Long-term follow-up of patients treated with topiramate for partial seizures
-
Ben-Menachem E. Long-term follow-up of patients treated with topiramate for partial seizures. Epilepsia 36 Suppl. 3 (1995) S152
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 3
-
-
Ben-Menachem, E.1
-
4
-
-
0043181917
-
Double-blind placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
-
Ben-Menachem E., Henriksen O., Dam M., Mikkelsen M., Schmidt D., Reid S., Reife R., Kramer L., Pledger G., and Karim R. Double-blind placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37 6 (1996) 539-543
-
(1996)
Epilepsia
, vol.37
, Issue.6
, pp. 539-543
-
-
Ben-Menachem, E.1
Henriksen, O.2
Dam, M.3
Mikkelsen, M.4
Schmidt, D.5
Reid, S.6
Reife, R.7
Kramer, L.8
Pledger, G.9
Karim, R.10
-
5
-
-
0034162331
-
A multi-centre, double-blind, randomised, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy
-
Betts T., Waegemans T., and Crawford P. A multi-centre, double-blind, randomised, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 9 (2000) 80-87
-
(2000)
Seizure
, vol.9
, pp. 80-87
-
-
Betts, T.1
Waegemans, T.2
Crawford, P.3
-
6
-
-
2042539816
-
Open-label study of UCB LO59 as add-on therapy in refractory partial epilepsy
-
Cameron N., Penovich P.E., Ritter F.J., and Espe-Lillo J. Open-label study of UCB LO59 as add-on therapy in refractory partial epilepsy. Epilepsia 37 Suppl. 5 (1996) 169
-
(1996)
Epilepsia
, vol.37
, Issue.SUPPL. 5
, pp. 169
-
-
Cameron, N.1
Penovich, P.E.2
Ritter, F.J.3
Espe-Lillo, J.4
-
7
-
-
0033854805
-
Levetiracetam for partial seizures: results of a double-blind randomised clinical trial
-
Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., and Leppik I. Levetiracetam for partial seizures: results of a double-blind randomised clinical trial. Neurology 55 (2000) 236-242
-
(2000)
Neurology
, vol.55
, pp. 236-242
-
-
Cereghino, J.J.1
Biton, V.2
Abou-Khalil, B.3
Dreifuss, F.4
Gauer, L.J.5
Leppik, I.6
-
8
-
-
84970861456
-
Identifying relevant studies for systematic reviews
-
Dickersin K., Scherer R., and Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 309 (1994) 1286-1291
-
(1994)
BMJ
, vol.309
, pp. 1286-1291
-
-
Dickersin, K.1
Scherer, R.2
Lefebvre, C.3
-
9
-
-
4744338860
-
Breaching the contract: the ethics of non-publication of research studies
-
Dowd D. Breaching the contract: the ethics of non-publication of research studies. Arch. Pediatr. Adolesc. Med. 158 (2004) 1014-1015
-
(2004)
Arch. Pediatr. Adolesc. Med.
, vol.158
, pp. 1014-1015
-
-
Dowd, D.1
-
10
-
-
35548966748
-
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
-
STROBE Initiative
-
Elm E.V., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., and STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335 (2007) 806-808
-
(2007)
BMJ
, vol.335
, pp. 806-808
-
-
Elm, E.V.1
Altman, D.G.2
Egger, M.3
Pocock, S.J.4
Gøtzsche, P.C.5
Vandenbroucke, J.P.6
-
11
-
-
0000337337
-
Long term effect of topiramate in refractory partial epilepsy
-
Engelskjon T., Johannessen S.I., Kloster R., Nakken K., Lossius R., and Henriksen O. Long term effect of topiramate in refractory partial epilepsy. Epilepsia 34 Suppl. 2 (1993) 123
-
(1993)
Epilepsia
, vol.34
, Issue.SUPPL. 2
, pp. 123
-
-
Engelskjon, T.1
Johannessen, S.I.2
Kloster, R.3
Nakken, K.4
Lossius, R.5
Henriksen, O.6
-
12
-
-
0011083923
-
Long term therapy with topiramate in patients with partial seizures.
-
Fincham R., and Schottelius D. Long term therapy with topiramate in patients with partial seizures. Epilepsia 36 Suppl. 4 (1995) 56
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 4
, pp. 56
-
-
Fincham, R.1
Schottelius, D.2
-
13
-
-
0027988184
-
Efficacy and tolerance of long-term, high-dose gabapentin: additional observations
-
Handforth A., and Treiman D.M. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations. Epilepsia 35 5 (1994) 1032-1037
-
(1994)
Epilepsia
, vol.35
, Issue.5
, pp. 1032-1037
-
-
Handforth, A.1
Treiman, D.M.2
-
14
-
-
38349070361
-
Open-label extension studies and patient selection biases
-
Hemming K., Hutton J.L., Maguire M.J., and Marson A.G. Open-label extension studies and patient selection biases. J. Eval. Clin. Pract. 14 1 (2008) 141-144
-
(2008)
J. Eval. Clin. Pract.
, vol.14
, Issue.1
, pp. 141-144
-
-
Hemming, K.1
Hutton, J.L.2
Maguire, M.J.3
Marson, A.G.4
-
15
-
-
0030873963
-
New anti-epileptic drugs: a systematic review of their efficacy and tolerability
-
Marson A.G., Kadir Z.A., and Chadwick D.W. New anti-epileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38 8 (1997) 859-880
-
(1997)
Epilepsia
, vol.38
, Issue.8
, pp. 859-880
-
-
Marson, A.G.1
Kadir, Z.A.2
Chadwick, D.W.3
-
16
-
-
0011083925
-
Topiramate in the treatment of refractory partial epilepsy: a 2 year long-term follow-up
-
Michelucci R., Passarelli D., and Tassinari C.A. Topiramate in the treatment of refractory partial epilepsy: a 2 year long-term follow-up. Epilepsia 37 Suppl. 4 (1996) 70
-
(1996)
Epilepsia
, vol.37
, Issue.SUPPL. 4
, pp. 70
-
-
Michelucci, R.1
Passarelli, D.2
Tassinari, C.A.3
-
17
-
-
0011107199
-
Topiramate as long-term treatment in refractory partial epilepsy
-
Mikkelsen M., Ostergaard L., and Dam M. Topiramate as long-term treatment in refractory partial epilepsy. Epilepsia 34 Suppl. 2 (1993) 123
-
(1993)
Epilepsia
, vol.34
, Issue.SUPPL. 2
, pp. 123
-
-
Mikkelsen, M.1
Ostergaard, L.2
Dam, M.3
-
18
-
-
0026443052
-
Long term treatment with gabapentin for partial epilepsy
-
Ojemann L.M., Wilensky A.J., Temkin N.R., Chmelir T., Ricker B.A., and Wallace J. Long term treatment with gabapentin for partial epilepsy. Epilepsy Res. 13 (1992) 159-165
-
(1992)
Epilepsy Res.
, vol.13
, pp. 159-165
-
-
Ojemann, L.M.1
Wilensky, A.J.2
Temkin, N.R.3
Chmelir, T.4
Ricker, B.A.5
Wallace, J.6
-
19
-
-
0001196978
-
Long-term efficacy and safety of topiramate
-
Privitera M. Long-term efficacy and safety of topiramate. Epilepsia 36 Suppl. 3 (1995) S152
-
(1995)
Epilepsia
, vol.36
, Issue.SUPPL. 3
-
-
Privitera, M.1
-
20
-
-
0029884747
-
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
-
Privitera M., Fincham R., Penry J., Reife R., Kramer L., Pledger G., and Karim R. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Neurology 46 6 (1996) 1678-1683
-
(1996)
Neurology
, vol.46
, Issue.6
, pp. 1678-1683
-
-
Privitera, M.1
Fincham, R.2
Penry, J.3
Reife, R.4
Kramer, L.5
Pledger, G.6
Karim, R.7
-
21
-
-
24644450203
-
Long term efficacy of gabapentin in the treatment of partial seizures
-
Schear M.J., Wiener J.A., and Rowan A.J. Long term efficacy of gabapentin in the treatment of partial seizures. Epilepsia 32 Suppl. 3 (1991) 6
-
(1991)
Epilepsia
, vol.32
, Issue.SUPPL. 3
, pp. 6
-
-
Schear, M.J.1
Wiener, J.A.2
Rowan, A.J.3
-
22
-
-
10244250992
-
Adjuvant topiramate in intractable partial epilepsy
-
Sharief M.K., Sander J.W., Patsalos P.N., and Shorvon S.D. Adjuvant topiramate in intractable partial epilepsy. Epilepsia 34 Suppl. 6 (1993) 41
-
(1993)
Epilepsia
, vol.34
, Issue.SUPPL. 6
, pp. 41
-
-
Sharief, M.K.1
Sander, J.W.2
Patsalos, P.N.3
Shorvon, S.D.4
-
23
-
-
10544255353
-
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
-
Sharief M., Viteri C., Ben-Menachem E., Weber M., Reife R., Pledger G., and Karim R. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res. 25 (1996) 217-224
-
(1996)
Epilepsy Res.
, vol.25
, pp. 217-224
-
-
Sharief, M.1
Viteri, C.2
Ben-Menachem, E.3
Weber, M.4
Reife, R.5
Pledger, G.6
Karim, R.7
-
24
-
-
0026095572
-
Double-blind study of gabapentin in the treatment of partial seizures
-
Sivenius J., Kalviainen R., Ylinen A., and Riekkinen P. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 32 4 (1991) 539-542
-
(1991)
Epilepsia
, vol.32
, Issue.4
, pp. 539-542
-
-
Sivenius, J.1
Kalviainen, R.2
Ylinen, A.3
Riekkinen, P.4
-
25
-
-
0028145474
-
Long-term study with gabapentin in patients with drug-resistant epileptic seizures
-
Sivenius J., Ylinen A., Kalviainen R., and Riekkinen Sr. P.J. Long-term study with gabapentin in patients with drug-resistant epileptic seizures. Arch. Neurol. 51 (1994) 1047-1050
-
(1994)
Arch. Neurol.
, vol.51
, pp. 1047-1050
-
-
Sivenius, J.1
Ylinen, A.2
Kalviainen, R.3
Riekkinen Sr., P.J.4
-
26
-
-
9444251680
-
Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
-
Tassinari C.A., Michelucci R., Chauvel P., Chodkiewicz J., Shorvon S., Henriksen O., Dam M., Reife R., Pledger G., and Karim R. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 37 8 (1996) 763-768
-
(1996)
Epilepsia
, vol.37
, Issue.8
, pp. 763-768
-
-
Tassinari, C.A.1
Michelucci, R.2
Chauvel, P.3
Chodkiewicz, J.4
Shorvon, S.5
Henriksen, O.6
Dam, M.7
Reife, R.8
Pledger, G.9
Karim, R.10
-
27
-
-
24644446896
-
Open label extension studies: research or marketing?
-
Taylor G.J., and Wainwright P. Open label extension studies: research or marketing?. Brit. Med. J. 331 7516 (2005) 572-574
-
(2005)
Brit. Med. J.
, vol.331
, Issue.7516
, pp. 572-574
-
-
Taylor, G.J.1
Wainwright, P.2
-
28
-
-
0027374164
-
Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study
-
The US Gabapentin Study Group No 5
-
The US Gabapentin Study Group No 5. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. Neurology 43 (1993) 2292-2298
-
(1993)
Neurology
, vol.43
, pp. 2292-2298
-
-
-
29
-
-
0028343267
-
The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug resistant partial epilepsy
-
The US Gabapentin Study Group
-
The US Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug resistant partial epilepsy. Epilepsy Res. 18 (1994) 67-73
-
(1994)
Epilepsy Res.
, vol.18
, pp. 67-73
-
-
|